TORONTO--(BUSINESS WIRE)--According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, pharmacomechanical thrombectomy devices, which combine direct delivery of “clot-busting” thrombolytic drugs with mechanical clot disruption, while expensive, will show the largest growth among clot management devices between 2011 and 2015.
